DE69215761T2 - Thioxanthenone als Antitumormittel - Google Patents

Thioxanthenone als Antitumormittel

Info

Publication number
DE69215761T2
DE69215761T2 DE69215761T DE69215761T DE69215761T2 DE 69215761 T2 DE69215761 T2 DE 69215761T2 DE 69215761 T DE69215761 T DE 69215761T DE 69215761 T DE69215761 T DE 69215761T DE 69215761 T2 DE69215761 T2 DE 69215761T2
Authority
DE
Germany
Prior art keywords
thioxanthenones
tumor agents
disclosed
thioxanthen
dialkylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69215761T
Other languages
English (en)
Other versions
DE69215761D1 (de
Inventor
Theodore C Miller
Michael E Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Application granted granted Critical
Publication of DE69215761D1 publication Critical patent/DE69215761D1/de
Publication of DE69215761T2 publication Critical patent/DE69215761T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12—Thioxanthenes
    • C07D335/14—Thioxanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D335/16—Oxygen atoms, e.g. thioxanthones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69215761T 1991-06-10 1992-06-03 Thioxanthenone als Antitumormittel Expired - Fee Related DE69215761T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/713,172 US5091410A (en) 1991-06-10 1991-06-10 Thioxanthenone antitumor agents

Publications (2)

Publication Number Publication Date
DE69215761D1 DE69215761D1 (de) 1997-01-23
DE69215761T2 true DE69215761T2 (de) 1997-06-05

Family

ID=24865076

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69215761T Expired - Fee Related DE69215761T2 (de) 1991-06-10 1992-06-03 Thioxanthenone als Antitumormittel

Country Status (13)

Country Link
US (1) US5091410A (de)
EP (1) EP0518413B1 (de)
JP (1) JP3045355B2 (de)
AT (1) ATE146172T1 (de)
AU (1) AU643138B2 (de)
CA (1) CA2070799C (de)
DE (1) DE69215761T2 (de)
DK (1) DK0518413T3 (de)
ES (1) ES2098435T3 (de)
GR (1) GR3022725T3 (de)
IE (1) IE78824B1 (de)
MX (1) MX9202752A (de)
SG (1) SG48022A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346917A (en) * 1991-06-10 1994-09-13 Sterling Winthrop Inc. Thioxanthenone antitumor agents
AU642596B2 (en) * 1991-06-10 1993-10-21 Sanofi-Synthelabo Thioxanthenone antitumor agents
US5665760A (en) * 1995-09-18 1997-09-09 Sanofi Winthrop, Inc. Lyophilized thioxanthenone antitumor agents
US10842776B2 (en) * 2016-06-28 2020-11-24 Assistance Publique—Hopitaua de Paris Hycanthone derivatives and Primaquine derivatives for use in the prevention and/or the treatment of disorders associated to gammaherpesvirus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577441A (en) * 1967-03-07 1971-05-04 Warner Lambert Pharmaceutical Nitro substituted benzofurans
US3577558A (en) * 1968-04-15 1971-05-04 Sterling Drug Inc 1-aminoalkylamino-4-alkoxymethylthioxanthene derivatives
US4539412A (en) * 1982-07-08 1985-09-03 Rensselaer Polytechnic Institute 7-Hydroxylucanthone, 7-hydroxhycanthone and their analogs
US4582851A (en) * 1984-02-06 1986-04-15 Warner-Lambert Company Anti-bacterial 1,4-aminoalkylamino-9H-thioxanthen-9-one derivatives, compositions, and method of use therefor
AU642596B2 (en) * 1991-06-10 1993-10-21 Sanofi-Synthelabo Thioxanthenone antitumor agents

Also Published As

Publication number Publication date
SG48022A1 (en) 1998-04-17
AU1704592A (en) 1992-12-17
EP0518413B1 (de) 1996-12-11
DK0518413T3 (da) 1997-06-02
ATE146172T1 (de) 1996-12-15
US5091410A (en) 1992-02-25
EP0518413A1 (de) 1992-12-16
JP3045355B2 (ja) 2000-05-29
CA2070799C (en) 2005-11-29
AU643138B2 (en) 1993-11-04
IE78824B1 (en) 1998-02-25
CA2070799A1 (en) 1992-12-11
IE921872A1 (en) 1992-12-16
ES2098435T3 (es) 1997-05-01
DE69215761D1 (de) 1997-01-23
GR3022725T3 (en) 1997-06-30
JPH05262760A (ja) 1993-10-12
MX9202752A (es) 1994-05-31

Similar Documents

Publication Publication Date Title
EG17765A (en) Method of treating tumors in mammals
ATE187175T1 (de) Adenosinkinaseinhibitoren
DZ2043A1 (fr) Nouveaux dérivés.
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
FI965008A0 (fi) Koostumukset ja menetelmät kasvainten hoitamiseksi
DE69215761T2 (de) Thioxanthenone als Antitumormittel
DE69724472D1 (de) Selenophen-antitumormittel
GB2185017A (en) Seco-sterol compounds effective in inducing the differentiation of malignant cells
NO973871L (no) Benzotiopyranoindazoler som antitumormidler
DE3879709D1 (de) Platin-arzneimittel.
NZ219093A (en) (gem-heterocyclodimethanamine-n,n') platinum complexes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI, PARIS, FR

8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-SYNTHELABO, PARIS, FR

8328 Change in the person/name/address of the agent

Free format text: MUELLER, SCHUPFNER & GAUGER, 80539 MUENCHEN

8339 Ceased/non-payment of the annual fee